Niga-ichigoside F1 alleviates DSS-induced ulcerative colitis by inhibiting the NF-κB pathway

被引:0
|
作者
Zhu, Siyi [1 ]
Xu, Peng [1 ]
Chen, Shuai [2 ]
Wang, Zheng [1 ]
机构
[1] Hunan Agr Univ, Coll Biosci & Biotechnol, 1 Nong Da Rd, Changsha 410128, Peoples R China
[2] Wuhan Univ, Sch Publ Hlth, 299 Ba Yi Rd, Wuhan 430071, Peoples R China
关键词
Niga-ichigoside F1; Colitis; NF-kappa B; Network pharmacology; Molecular docking; 23-HYDROXYTORMENTIC ACID; RUBUS-IMPERIALIS; MCP-1; F-1;
D O I
10.1016/j.fbio.2024.104834
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Niga-ichigoside F1, an ursolic acid-type pentacyclic triterpenoid, possesses various pharmacological properties, including anti-tumor, anti-inflammatory, and antinociceptive potentials. However, its function and underlying mechanism in ulcerative colitis (UC) remain unknown. Hence, this study aimed to explore the effect of Nigaichigoside F1 on dextran sulfate sodium (DSS)-induced colitis. The predictive results of network pharmacology identified 311 common targets of Niga-ichigoside F1 and ulcerative colitis. The 4 highest-scoring genes were screened by the BottleNeck method and they were, signal transducer and activator of transcription 3 (STAT3), tumor necrosis factor (TNF), protein kinase B gamma (AKT3), and phosphatidylinositol-4,5bisphosphate 3-kinase, catalytic subunit beta (PIK3CB). KEGG pathway analysis indicated that Niga-ichigoside F1 probably exerted a protective effect on UC through the nuclear factor-kappa B (NF-kappa B) pathways. Molecular docking results showed that Niga-ichigoside F1 had a high affinity for nuclear factor-kappa B-inhibitor of nuclear factor-kappa B (NF-kappa B-I kappa B) complex, with the lowest binding energy. Furthermore, our results in vivo showed that Niga-ichigoside F1 alleviated weight loss, colon shortening, disease activity index (DAI), and histological scoring in DSS-induced colitis mice. Moreover, Niga-ichigoside F1 decreased the levels of inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-8 (IL-8) and the expression of oxidative stress markers nitric oxide (NO), myeloperoxidase (MPO), and malonaldehyde (MDA) to mitigate inflammation and intestinal damage. Western blotting results evidenced that Nigaichigoside F1 intervention significantly regulated the NF-kappa B pathway. In conclusion, this study highlighted the potential of Niga-ichigoside F1 in ameliorating colitis, indicating its potential application as a functional food.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Alginate Oligosaccharides Ameliorate DSS-Induced Colitis through Modulation of AMPK/NF-κB Pathway and Intestinal Microbiota
    Zhang, Yue
    Guo, Congcong
    Li, Yanru
    Han, Xianlei
    Luo, Xuegang
    Chen, Liehuan
    Zhang, Tongcun
    Wang, Nan
    Wang, Weiming
    NUTRIENTS, 2022, 14 (14)
  • [32] Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway
    Ren, Yijing
    Yue, Bei
    Ren, Gaiyan
    Yu, Zhilun
    Luo, Xiaoping
    Sun, Aning
    Zhang, Jingjing
    Han, Mengqing
    Wang, Zhengtao
    Dou, Wei
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Timosaponin BII reduces colonic inflammation and alleviates DSS-induced ulcerative colitis by inhibiting NLRP3
    Feng, Meng
    Zhou, Yingya
    Gao, Zhenyu
    Huang, Wenni
    Xie, Wenmin
    Xie, Wanlin
    Liu, Zhenyv
    Tang, Shengzhao
    Xiong, Xuejun
    Chen, Yijun
    Zhou, Xinxin
    Liu, Changhui
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 325
  • [34] Network pharmacology and experimental verification revealing valnemulin alleviates DSS-induced ulcerative colitis by inhibiting intestinal senescence
    Wang, Zhiwei
    Lian, Wei
    Chen, Cui
    Dai, Qianlong
    Liu, Zhenlin
    Liu, Jiayu
    Zhang, Yuanyuan
    Zhou, Min
    Wang, Xiaobo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 141
  • [35] Rubus imperialis (Rosaceae) extract and pure compound niga-ichigoside F1: wound healing and anti-inflammatory effects
    Tonin, Talita Dacroce
    Thiesen, Liliani Carolini
    de Oliveira Nunes, Maria Luisa
    Broering, Milena Fronza
    Donato, Marcos Paulo
    Goss, Marina Jagielski
    Petreanu, Marcel
    Niero, Rivaldo
    Machado, Isabel Daufenback
    Santin, Jose Roberto
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (11) : 1235 - 1244
  • [36] Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway
    Yijing Ren
    Bei Yue
    Gaiyan Ren
    Zhilun Yu
    Xiaoping Luo
    Aning Sun
    Jingjing Zhang
    Mengqing Han
    Zhengtao Wang
    Wei Dou
    Scientific Reports, 9
  • [37] Sericic Acid Ameliorates DSS-induced Ulcerative Colitis in Mice by Modulating the NF-κB and Nrf2 Pathways
    Lifei-Luo
    Zhang, Jingze
    Li, Xinyu
    Zhu, Yanru
    Wang, Yansheng
    Liu, Dailin
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (07) : 759 - 770
  • [38] Stachyose modulates gut microbiota and alleviates DSS-induced ulcerative colitis in mice
    Chen Wang
    Junying Bai
    Botao Wang
    Leilei Yu
    Fengwei Tian
    Jianxin Zhao
    Hao Zhang
    Huayi Suo
    Wei Chen
    Qixiao Zhai
    Food Science and Human Wellness, 2023, 12 (06) : 2211 - 2220
  • [39] Stachyose modulates gut microbiota and alleviates DSS-induced ulcerative colitis in mice
    Wang, Chen
    Bai, Junying
    Wang, Botao
    Yu, Leilei
    Tian, Fengwei
    Zhao, Jianxin
    Zhang, Hao
    Suo, Huayi
    Chen, Wei
    Zhai, Qixiao
    FOOD SCIENCE AND HUMAN WELLNESS, 2023, 12 (06) : 2211 - 2220
  • [40] Macrophage β-arrestin-1 deteriorates DSS-induced colitis through interaction with NF-κB signaling
    Ke, Ping
    Zhu, Dan-Ni
    Liu, Meng-Zhen
    Yan, Hui
    Zhao, Qing-Jie
    Du, Jing
    Wei, Wei
    Chen, Xiong-Wen
    Liu, Chong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130